Kolkata, March 26: Cipla Health Limited has announced the launch of a new ‘Masala Guava’ variant under its flagship brand Prolyte ORS, a W.H.O.-recommended Oral Rehydration Salt (ORS) formulation. Designed with Indian consumers at its core, the new flavour combines the proven efficacy of ORS with a taste inspired by local preferences—making hydration both effective and enjoyable.
With this launch, Cipla Health strengthens its presence in the oral rehydration segment, where Prolyte ORS has long been a trusted name. The addition of the Masala Guava variant expands the portfolio to eleven flavours, all rooted in science while evolving to meet growing consumer demand for hydration solutions that offer both effectiveness and taste without compromise.
Commenting on the launch, Shivam Puri, CEO and MD, Cipla Health Limited, said, “Hydration is fundamental to maintaining overall health and wellbeing, especially in a country like India where climatic conditions and active lifestyles increase the risk of dehydration. Prolyte ORS has always stood for science you can trust. With the addition of Masala Guava, we aim to make it a preferred choice not just during illness, but as part of a smarter, everyday hydration habit.”
The new variant is the result of extensive research and development, balancing precise formulation standards with consumer taste preferences. The flavour has undergone multiple rounds of testing to ensure it meets stringent quality and efficacy benchmarks while delivering a familiar and appealing taste.
